Polymers and nanogel materials and methods for making and using the same

US9726906B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9726906-B2
Application numberUS-201514948474-A
CountryUS
Kind codeB2
Filing dateNov 23, 2015
Priority dateMay 25, 2012
Publication dateAug 8, 2017
Grant dateAug 8, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolymers may be incorporated into a formulation from which the article is made or may be contacted with the article post-formation.

First claim

Opening claim text (preview).

What is claimed is: 1. A process comprising contacting a contact lens with a solution comprising a lipid uptake reducing amount of at least one water soluble, crosslinked copolymer under contacting conditions suitable to associate said copolymer with said contact lens; wherein said cross-linked copolymer comprises a plurality of crosslinked primary polymer chains each having a degree of polymerization in the range of about 10 to about 10,000, wherein said cross-linked copolymer does not comprise repeating units derived from a substituted or unsubstituted acrylic acid bonded directly to the polymer backbone. 2. The process of claim 1 wherein said contact lens comprises a silicone hydrogel contact lens. 3. The process of claim 1 wherein said water soluble, cross-linked copolymer has a cross-linker to primary polymer chain molar ratio in the range of about 0.01 to about 3. 4. The process of claim 1 wherein said lipid uptake reducing amount is at least about 10 ppm. 5. The process of claim 1 wherein said lipid uptake reducing amount is in the range of about 10 ppm to about 10,000 ppm. 6. The process of claim 1 wherein the lipid uptake by the lens is no more than about 10 μg/lens. 7. The process of claim 1 , wherein said primary polymer chains are selected from the group consisting of hydrophilic polymers and copolymers, proton donating polymers and copolymers, proton accepting polymers and copolymers, ionic polymers and copolymers, complexing polymers and copolymers, stimuli responsive polymers and copolymers and mixtures thereof. 8. The process of claim 7 , wherein the proton donating polymers and copolymers comprise one or more alcohols. 9. The process of claim 7 , wherein the proton accepting polymers and copolymers comprise one or more amides. 10. The process of claim 7 , wherein the ionic polymers and copolymers comprise one or more of the following: a carboxylate, a sulfonate, an ammonium salt, and a phosphonium salt. 11. The process of claim 7 , wherein the complexing polymers and copolymers comprise one or more boronic acid functionalities and/or hydroxyl functionalities. 12. The process of claim 7 , wherein the stimuli responsive polymers and copolymers comprise a polymer selected from the group consisting of temperature-responsive polymers, pH responsive polymers, electrolyte responsive polymers, light responsive polymers and mixtures thereof. 13. The process of claim 12 , wherein the temperature-responsive polymer is poly(N-isopropylacrylamide). 14. The process of claim 7 wherein the copolymers are both hydrophilic and proton donating. 15. The process of claim 14 wherein the copolymers comprise repeating units derived from the polymerization of at least one monomer selected from the group consisting of N-vinyl pyrrolidone, N,N-dimethyl acrylamide, and N-hydroxypropyl methacrylamide. 16. The process of claim 1 wherein the copolymers are formed from monomers selected from the group consisting of vinyl amides, vinyl lactones, vinylimides, vinyl lactams, hydrophilic (meth)acrylates, (meth)acrylamides, and mixtures thereof. 17. The process of claim 1 wherein said primary polymer chains are cross-linked by at least one cross-linking agent selected from the group consisting of an N,N′-alkylenebis(meth)acrylamide, polyalkyleneglycoldi(meth)acrylate, polyalkyleneglycoldi(meth)acrylamide, and combinations thereof. 18. The process of claim 1 wherein said primary polymer chains independently have a degree of polymerization in the range of about 50 to about 5,000. 19. The process of claim 1 wherein said primary polymer chains independently have a degree of polymerization in the range of about 100 to about 1000. 20. The process of claim 1 wherein said primary polymer chains independently have a degree of polymerization in the range of about 100 to about 500. 21. The process of claim 1 wherein said primary polymer chains independently have a degree of polymerization in the range of about 100 to about 300. 22. The process of claim 1 wherein said cross-linked copolymer has a cross-linker to primary polymer chain molar ratio in the range of about 0.01 to about 3. 23. The process of claim 1 wherein said primary polymer chains are cross-linked to other primary polymer chains of said hydrophilic nanogel having polydispersity indices (PDIs) of less than about 1.5. 24. The process of claim 22 wherein said primary polymer chains are cross-linked by covalent bonding, ionic bonding, hydrogen bonding, or a combination thereof. 25. The process of claim 1 wherein said primary polymer chains, ζ, are represented by the formula wherein R 1 is a divalent group selected from the group consisting of optionally substituted alkylene; optionally substituted saturated, unsaturated or aromatic carbocyclic or heterocyclic rings; optionally substituted alkylthio; optionally substituted alkoxy; or optionally substituted dialkylamino; U is independently selected from the group consisting of hydrogen, halogen, C 1 -C 4 alkyl which may be optionally substituted with hydroxyl, alkoxy, aryloxy (OR″), carboxy, acyloxy, aroyloxy (O 2 CR″), alkoxy-carbonyl, aryloxy-carbonyl (CO 2 R″) and combinations thereof; V is independently selected from the group consisting of R″, —CO 2 R″, —COR″, —CN, —CONH 2 , —CONHR″, —CONR″ 2 , —O 2 CR″, —OR″, cyclic and acyclic N-vinyl amides and combinations thereof; R″ is independently selected from the group consisting of optionally substituted C 1 -C 18 alkyl, C 2 -C 18 alkenyl, aryl, heterocyclyl, alkaryl wherein the substituents are independently selected from the group that consists of epoxy, hydroxyl, alkoxy, acyl, acyloxy, carboxy, carboxylate, sulfonic acid, and sulfonate, alkoxy- or aryloxy-carbonyl, isocyanato, cyano, silyl, halo, dialkylamino; phosphoric acids, phosphates, phosphonic acids, phosphonates and combinations thereof; R 15 ′ and R 15 are residues of hydrophilic, free radical reactive cross-linking agents; R 18 is a controlled radical polymerization agent; ζ i is another primary chain, are mole fractions, and α is equal to about 0.85 to about 0.999, β is not 0, and the mole fractions of β and γ combined are about 0.15 to about 0.001. 26. The process of claim 25 wherein said primary polymer chains, ζ, are represented by the formula Wherein R 1 , U, V, R 15 , R 15′ , α, β, γ and m are as defined in claim 25 . 27. The process of claim 25 or 26 wherein R 1 is selected from the group consisting of 4-cyanopentanoate, isobutanoic, or a benzylic group. 28. The process of claim 25 or 26 wherein R 1 is selected from the group consisting of a cyano-methy or cumyl group. 29. The process of claim 25 or 26 wherein R 1 is polyvalent. 30. The process of claim 25 or 26 wherein U is selected from H or methyl. 31. The process of claim 25 or 26 wherein R″ is selected from the group consisting of methyl, —CH 2 OH, —CH 2 CH 2 OH, —CH 2 CH 2 CH 2 OH, —CH 2 —CO 2 − , —CH 2 CH 2 —CO 2 − , —CH 2 CH 2 CH 2 —CO 2 − , —CH 2 CH 2 CH 2 CH 2 —CO 2 − , —CH 2 CH 2 CH 2 CH 2 CH 2 —CO 2 − , —CH 2 —SO 3 − , —C

Assignees

Inventors

Classifications

  • G02B1/043Primary

    Contact lenses · CPC title

  • Laminated or compound lenses · CPC title

  • G02C7/049Primary

    Contact lenses having special fitting or structural features achieved by special materials or material structures · CPC title

  • Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur with or without nitrogen, oxygen or carbon only; Compositions of polysulfones; Compositions of derivatives of such polymers · CPC title

  • the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9726906B2 cover?
Provided are articles such as medical devices which comprise at least one water soluble, crosslinked copolymer. The primary polymer chains of the copolymer are hydrophilic and independently have a degree of polymerization in the range of about 10 to about 10,000. The water soluble, crosslinked copolymers of the present invention are free from terminal substrate associating segments. The copolym…
Who is the assignee on this patent?
Johnson & Johnson Vision Care
What technology area does this patent fall under?
Primary CPC classification G02B1/043. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).